Northwest Wealth Management »

Alnylam Pharmaceuticals shares owned by Northwest Wealth Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Northwest Wealth Management from 13F filings

Historical chart of Northwest Wealth Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Northwest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Northwest Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $225k 565 397.65

More positions owned by Northwest Wealth Management

Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Dimensional Etf Trust Short Duration F (DFSD)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Core Msci Intl (IDEV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Equity Market (DFUS)
Apple (AAPL)
Dimensional Etf Trust Internatnal Val (DFIV)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Emgmkt (AVEM)

View all positions for Northwest Wealth Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals